In a 30‑month‑old child with anaphylaxis who was mistakenly given 1.4 mg of adrenaline, what parameters should be monitored?

Immediate Monitoring for Adrenaline Overdose in a 30-Month-Old Child

This child requires immediate continuous cardiac monitoring with ECG, blood pressure measurement every 1-2 minutes, and close observation for potentially lethal arrhythmias, as the 1.4 mg dose represents approximately 4-5 times the maximum recommended dose and carries significant risk of cardiovascular toxicity. 1

Critical Context

For a 30-month-old child (approximately 12-15 kg), the appropriate dose would be 0.12-0.15 mg (0.01 mg/kg, maximum 0.3 mg). The administered 1.4 mg dose is roughly 10-fold higher than appropriate and approaches doses used only in cardiac arrest scenarios 1.

The guidelines explicitly warn that "because of the risk for potentially lethal arrhythmias, epinephrine should be administered intravenously only during cardiac arrest" and emphasize that continuous hemodynamic monitoring is essential when higher doses are used 1.

Essential Monitoring Parameters

Cardiovascular Monitoring (Highest Priority)

• Continuous ECG monitoring for arrhythmias including:

  • Ventricular arrhythmias (potentially fatal ventricular fibrillation)
  • Tachyarrhythmias
  • Premature ventricular contractions
  • ST-segment changes indicating myocardial ischemia 1, 2

• Blood pressure measurement every 1-2 minutes initially, then every 5 minutes once stable:

  • Watch for severe hypertension (can cause cerebral hemorrhage) 3
  • Monitor for hypotension if compensatory mechanisms fail
  • Use appropriately sized pediatric cuff 4

• Heart rate monitoring continuously:

  • Expect significant tachycardia
  • Document trends 5

Clinical Assessment

• Mental status and neurological examination every 5-10 minutes:

  • Agitation, anxiety, restlessness
  • Headache (may indicate hypertensive crisis)
  • Altered consciousness
  • Seizure activity
  • Signs of intracranial hemorrhage 3

• Respiratory status:

  • Respiratory rate and effort
  • Oxygen saturation
  • Pulmonary edema signs (rare but possible with severe hypertension)

• Peripheral perfusion:

  • Skin color (pallor is expected)
  • Capillary refill
  • Extremity temperature
  • Pulse quality

Laboratory and Adjunctive Monitoring

• Continuous pulse oximetry
• Blood glucose (epinephrine causes hyperglycemia)
• Electrolytes if prolonged monitoring required
• Troponin if chest pain or ECG changes develop
• Arterial blood gas if respiratory compromise

Expected Toxic Effects vs. Therapeutic Effects

The child will likely experience exaggerated pharmacologic effects that overlap with toxicity 6:

• Cardiovascular: Severe tachycardia, hypertension, palpitations, arrhythmias
• Neurological: Marked anxiety, tremor, agitation, headache
• Metabolic: Hyperglycemia, hypokalemia (from β2-mediated intracellular shift)
• Other: Pallor, diaphoresis, nausea, vomiting

Duration of Monitoring

Minimum 4-6 hours of intensive monitoring is required because:

• Epinephrine has a short half-life (minutes), but cardiovascular effects can persist
• Peak plasma levels occur 5-10 minutes after IM injection
• Arrhythmias may develop during the peak effect period
• The massive overdose may have prolonged absorption from the injection site 7, 5

Management Setting

This child requires immediate transfer to a pediatric intensive care unit or emergency department with continuous monitoring capabilities 1. Do not attempt to manage this in a setting without:

• Continuous cardiac monitoring
• Immediate resuscitation capabilities
• Pediatric advanced life support resources

Common Pitfall to Avoid

Do not assume the child is stable based on initial appearance alone. The case report by 4 specifically highlights that signs of adrenaline overdose (hypertension, tachycardia) can be indistinguishable from progressive anaphylactic shock until blood pressure is actually measured. Blood pressure measurement is absolutely essential and should not be omitted 4.

Another critical case 3 demonstrates that even standard IM doses can cause hypertensive emergency with brainstem hemorrhage in susceptible patients—this overdose carries substantially higher risk.

Treatment Considerations

While monitoring, be prepared to treat:

• Severe hypertension: Short-acting antihypertensives (e.g., labetalol, esmolol) may be needed
• Arrhythmias: Per pediatric advanced cardiac life support protocols
• Seizures: Benzodiazepines if they occur
• Myocardial ischemia: Supportive care, oxygen

The anaphylaxis itself still requires appropriate management with antihistamines, corticosteroids, and supportive care, but the overdose toxicity is now the immediate life-threatening concern 1, 2.